Manulife (Manufacturers Life Insurance)
RGLS

Manulife (Manufacturers Life Insurance)’s Regulus Therapeutics RGLS Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-129,700
Closed -$204K – 3015
2024
Q3 		$204K Buy
+129,700
New +$215K ﹤0.01% 2662
2021
Q4 		– Sell
-1,061
Closed -$7K – 3168
2021
Q3 		$7K Hold
1,061
– – ﹤0.01% 3136
2021
Q2 		$9K Buy
+1,061
New +$11.8K ﹤0.01% 3215
2018
Q3 		– Sell
-50
Closed -$4K – 3694
2018
Q2 		$4K Hold
50
– – ﹤0.01% 4128
2018
Q1 		$4K Hold
50
– – ﹤0.01% 4155
2017
Q4 		$6K Buy
+50
New +$6.33K ﹤0.01% 4107
2017
Q3 		– Sell
-12
Closed -$1K – 4319
2017
Q2 		$1K Sell
12
-1
-8% -$167 ﹤0.01% 4245
2017
Q1 		$3K Sell
13
-68
-84% -$12.9K ﹤0.01% 3880
2016
Q4 		$22K Sell
81
-100
-55% -$32.5K ﹤0.01% 3601
2016
Q3 		$71K Sell
181
-65
-26% -$26.7K ﹤0.01% 3325
2016
Q2 		$85K Buy
246
+74
+43% +$53K ﹤0.01% 3249
2016
Q1 		$135K Buy
172
+5
+3% +$3.98K ﹤0.01% 2880
2015
Q4 		$175 Buy
167
+4
+2% +$4.01K ﹤0.01% 2756
2015
Q3 		$128 Hold
163
– – ﹤0.01% 2998
2015
Q2 		$215 Buy
163
+73
+81% +$118K ﹤0.01% 2788
2015
Q1 		$183 Buy
90
+9
+11% +$19.6K ﹤0.01% 2793
2014
Q4 		$156 Buy
81
+39
+93% +$69.4K ﹤0.01% 2828
2014
Q3 		$34 Buy
42
+26
+163% +$22K ﹤0.01% 3352
2014
Q2 		$15K Sell
16
-29
-64% -$24.9K ﹤0.01% 3357
2014
Q1 		$48 Buy
45
+29
+181% +$32.1K ﹤0.01% 3221
2013
Q4 		$14 Buy
16
+7
+78% +$6.03K ﹤0.01% 3316
2013
Q3 		$10 Buy
9
+1
+13% +$1.18K ﹤0.01% 3257
2013
Q2 		$9K Buy
+8
New +$7.61K ﹤0.01% 3194

Other funds holding RGLS

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s RGLS Position: Q4 2024 in Review

Manulife (Manufacturers Life Insurance) sold out of Regulus Therapeutics (RGLS) in Q4 2024, closing a stake of 129,700 shares — an estimated $204K sold.

Manulife (Manufacturers Life Insurance) first reported a position in RGLS in Q2 2013 and held it in 23 quarters. The position peaked at $204K in Q3 2024. 69 funds tracked by Wall St. Rank hold RGLS as of Q4 2024.

  • Manulife (Manufacturers Life Insurance) reported no remaining Regulus Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 129,700 Regulus Therapeutics shares in Q4 2024, an estimated $204K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Regulus Therapeutics in Q2 2013 and held it in 23 quarters.
  • Manulife (Manufacturers Life Insurance)'s Regulus Therapeutics position peaked at $204K in Q3 2024.
  • 69 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q4 2024.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2024, filed 14 Feb 2025.